JP Morgan Downgrades Qiagen to Neutral, Lowers Price Target to $52
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsDowngradesPrice Target
JP Morgan analyst Casey Woodring downgrades Qiagen (NYSE:QGEN) from Overweight to Neutral and lowers the price target from $55 to $52.
JP Morgan analyst Casey Woodring downgrades Qiagen (NYSE:QGEN) from Overweight to Neutral and lowers the price target from $55 to $52.